Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Authors:

Abstract
No abstract available
Funding Information
  • Reumatikerförbundet

This publication has 22 references indexed in Scilit: